Fascin actin-bundling protein 1 in human cancer: promising biomarker or therapeutic target?

H Liu, Y Zhang, L Li, J Cao, Y Guo, Y Wu… - Molecular Therapy …, 2021 - cell.com
Fascin actin-bundling protein 1 (FSCN1) is a highly conserved actin-bundling protein that
cross links F-actin microfilaments into tight, parallel bundles. Elevated FSCN1 levels have …

A systematic review of proteomic biomarkers in oral squamous cell cancer

J Pillai, T Chincholkar, R Dixit, M Pandey - World Journal of Surgical …, 2021 - Springer
Background Head and neck squamous cell cancer (HNSCC) is the most common cancer
associated with chewing tobacco, in the world. As this is divided in to sites and subsites, it …

Epithelial mesenchymal transition (EMT) and associated invasive adhesions in solid and haematological tumours

D Greaves, Y Calle - Cells, 2022 - mdpi.com
In solid tumours, cancer cells that undergo epithelial mesenchymal transition (EMT) express
characteristic gene expression signatures that promote invasive migration as well as the …

Plectin in cancer: from biomarker to therapeutic target

SM Perez, LT Brinton, KA Kelly - Cells, 2021 - mdpi.com
The cytolinker and scaffolding protein, plectin, has emerged as a potent driver of malignant
hallmarks in many human cancers due to its involvement in various cellular activities …

[HTML][HTML] FSCN1 acts as a promising therapeutic target in the blockade of tumor cell motility: a review of its function, mechanism, and clinical significance

Z Li, J Shi, N Zhang, X Zheng, Y Jin, S Wen… - Journal of …, 2022 - ncbi.nlm.nih.gov
Fascin actin-bundling protein 1 (FSCN1) is an actin-bundling protein that is capable of
inducing membrane protrusions and plays critical roles in cell migration, motility, adhesion …

New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells

B Alburquerque-González, M Bernabé-García… - … & Molecular Medicine, 2020 - nature.com
Serrated adenocarcinoma (SAC) is more invasive, has worse outcomes than conventional
colorectal carcinoma (CRC), and is characterized by frequent resistance to anti-epidermal …

The FDA-approved antiviral raltegravir inhibits fascin1-dependent invasion of colorectal tumor cells in vitro and in vivo

B Alburquerque-González, Á Bernabé-García… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer (CRC) is the third leading cause of cancer-related
deaths worldwide. Serrated adenocarcinoma (SAC) has been recently recognized by the …

[HTML][HTML] Pivotal role of microRNA-138 in human cancers

M Yeh, CS Oh, JY Yoo, B Kaur… - American journal of cancer …, 2019 - ncbi.nlm.nih.gov
Aberrant expression of certain microRNAs (miRNAs) has been implicated in cancers as a
promising druggable target due to the fact that a modulation of the deregulated single …

[HTML][HTML] Plectin: dual participation in tumor progression

Z Wang, W Wang, Q Luo, G Song - Biomolecules, 2024 - mdpi.com
The plectin gene can encode a cytoskeletal linking protein, plectin, known for its interaction
with three critical components of the cellular cytoskeleton: intermediate filaments …

[HTML][HTML] Molecular targets of pomegranate (Punica granatum) in preventing cancer metastasis

N Ahmadiankia - Iranian Journal of Basic Medical Sciences, 2019 - ncbi.nlm.nih.gov
Metastasis is the primary cause of mortality and morbidity among cancer patients and
accounts for about 90% of cancer deaths. The most common types of treatment for cancer …